Pegvisomant-primed growth hormone (GH) stimulation test is useful in identifying true GH deficient children
- 1 July 2017
- journal article
- research article
- Published by Springer Nature in Hormones
- Vol. 16 (3) , 291-296
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pegvisomant-primed GH stimulation testClinical Endocrinology, 2008
- Unreliability of classic provocative tests for the diagnosis of growth hormone deficiencyJournal of Endocrinological Investigation, 2008
- Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose toleranceEuropean Journal of Endocrinology, 2006
- Growth hormone secretory pattern and response to treatment in children with short stature followed to adult heightClinical Endocrinology, 2003
- Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and MenThe Journal of Clinical Endocrinology & Metabolism, 2002
- Height velocity and IGF‐I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?Clinical Endocrinology, 2002
- Growth Hormone Stimulation Testing in Both Short and Normal Statured Children: Use of an Immunofunctional AssayPediatric Research, 2000
- British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihoodStatistics in Medicine, 1998
- Variability of Growth Hormone Response to Pharmacological and Sleep Tests Performed Twice in Short ChildrenThe Journal of Clinical Endocrinology & Metabolism, 1990
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976